49.36 USD
↗ 1.78 (3.74%)LIVE (AS OF 03:19 PM EDT)
Spyre Therapeutics, Inc. Common Stock
SYRENASDAQ • USD
Market: OPEN
Open?$47.58
High?$52.12
Low?$45.00
Prev. Close?$47.58
Volume?443.3K
Avg. Volume?845.9K
VWAP?$48.83
Rel. Volume?0.52x
Bid / Ask
Bid?$48.20 × 100
Ask?$49.31 × 100
Spread?$1.11
Midpoint?$48.76
Valuation & Ratios
Market Cap?3.7B
Shares Out?78.5M
Float?64.9M
Float %?83.7%
P/E Ratio?N/A
P/B Ratio?5.22
EPS?-$1.61
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?13.25Strong
Quick Ratio?13.25Strong
Cash Ratio?1.46Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score83/100
P/E?N/A▾
P/B?5.22FAIR▾
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-16.6CHEAP▾
EV/Sales?N/A▾
Returns & Efficiency
ROE?-17.7%WEAK▾
ROA?-16.3%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$3.7B
Related Companies
Loading...
News
Profile
Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
Address
221 CRESCENT STREET
WALTHAM, MA 02453
Phone: (617) 651-5940
WALTHAM, MA 02453
Phone: (617) 651-5940